The protective barrier between healthy brain function and devastating neurodegeneration may hinge on a single protein's ability to anchor properly to cellular membranes. This discovery challenges the conventional focus on protein activity levels and redirects attention to subcellular positioning as a critical factor in brain health. A specific mutation (R152H) in glutathione peroxidase 4 disrupts the enzyme's membrane attachment without significantly reducing its catalytic function, yet triggers severe early-onset neurodegeneration through uncontrolled ferroptosis. Mouse models expressing this variant developed progressive cortical and cerebellar neuron loss accompanied by neuroinflammation, while patient-derived brain organoids showed heightened vulnerability to lipid peroxidation damage. Crucially, ferroptosis inhibitors could rescue these cellular models, demonstrating therapeutic potential. The affected brains exhibited proteomic signatures resembling Alzheimer's disease, suggesting ferroptosis may be an underrecognized driver across multiple neurodegenerative conditions. This represents a paradigm shift from viewing GPX4 purely as an antioxidant enzyme to understanding it as a membrane-tethered guardian whose precise cellular localization determines neuronal survival. The findings are particularly significant because ferroptosis represents a fundamentally different cell death pathway—one that operates without traditional apoptotic signals and instead depends on lipid oxidation cascades. For longevity-focused individuals, this research suggests that maintaining proper antioxidant protein function involves not just adequate levels, but ensuring these protective systems remain properly positioned within cells. The therapeutic implications are substantial, as ferroptosis inhibitors could potentially address neurodegeneration at its mechanistic root rather than managing downstream symptoms.